Read more

March 01, 2021
3 min read
Save

‘Significant variability’ exists in some early allergen introduction foods

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

There is “significant variability” in allergen composition, concentration and dose per serving among commercially available early allergen introduction foods, an expert told Healio Primary Care.

Perspective from Lakiea Wright, MD, MPH

The research was part of an online supplement to The Journal of Allergy and Clinical Immunology, published Feb. 1. The data are were also presented during the virtual American Academy of Allergy, Asthma and Immunology Annual Meeting.

A photo of peanut puffs, an EIF
Researchers found peanut allergen levels of up to 24,061 μg/g in peanut puffs, prompting them to call for guidelines that oversee early introduction allergy foods. Photo source: Adobe Stock.

“The rapid commercialization of [early allergen introduction foods (EIF)] has provided consumers and allergic families with a choice of EIF as aids for allergy prevention, which has several consequences,” Martin Chapman, BSc, PhD, president and CEO of INDOOR Biotechnologies, told Healio Primary Care. “The foods may be perceived as drugs or over-the-counter treatments and to have similar efficacy. Consumers may also consider them to be equally effective for different allergens.”

Martin Chapman

Chapman and Stephanie Filep, BS, director of laboratory services at INDOOR Biotechnologies, analyzed 86 extracts from 32 EIFs and four control foods. They used a “validated” fluorescent multiplex array to look for Ana o 3, Api g 1, Arah 1, Arah 3, Arah 6, Bos d 5, Bos d 11, Cor a 9, Cyp c 1, Gal d 1, Gal d 2, Gly m 5, Jug r 1, Ses I 1, Sin a 1, shrimp tropomyosin and Tri a 19 allergens.

“The individual allergens were selected because more than 50% of allergic patients react to these allergens by producing allergic (IgE) antibodies,” Chapman explained.

Chapman and Filep found that combined peanut allergen levels up to 24,061 g/g were measured in peanut puffs (doses of 56 mg-168 mg for each 7 g serving). Peanut allergens were “undetectable” in mixed food blend puffs. “Major” allergen levels above 10,000 g/g were identified in several milk, egg and peanut powders, with cumulative allergen doses of 147 mg-2,811 mg. Mixed food blend crackers, fruit sauces, puffs and powders had lower allergen levels — fewer than 10 g/g — and some had undetectable allergens. The researchers also reported that the allergen concentration in these EIFs varied over a three or greater log range and “provided lower cumulative doses of allergen” of fewer than 20 mg.

Chapman said the results were “not too surprising, given the challenges of formulating food products.” He encouraged health care providers to take the findings into consideration when choosing EIF products for themselves or their patients.

“Establishing guidelines for EIF would aid health care providers in determining the best treatment plan for their patients,” he added.